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Abstract
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Background
Due to frequent infections in cystic fibrosis (CF) patients, repeated respiratory cultures are
obtained to inform treatment. When patients are unable to expectorate sputum, clinicians
obtain throat swabs as a surrogate for lower respiratory cultures. There is no clear data in
adult subjects demonstrating the adequacy of throat swabs as a surrogate for sputum or
BAL. Our study was designed to determine the utility of throat swabs in identifying lung colonization with common organisms in adults with CF.

Editor: Abdelwahab Omri, Laurentian, CANADA
Received: July 15, 2016

Methods
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Adult CF subjects (n = 20) underwent bronchoscopy with BAL. Prior to bronchoscopy, a
throat swab was obtained. A sputum sample was obtained from subjects who were able to
spontaneously expectorate. All samples were sent for standard microbiology culture.
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Results
Using BAL as the gold standard, we found the positive predictive value for Pseudomonas
aeruginosa to be 100% in both sputum and throat swab compared to BAL. However, the
negative predictive value for P. aeruginosa was 60% and 50% in sputum and throat swab,
respectively. Conversely, the positive predictive value for Staphylococcus aureus was 57%
in sputum and only 41% in throat swab and the negative predictive value of S. aureus was
100% in sputum and throat swab compared to BAL.

Conclusions
Our data show that positive sputum and throat culture findings of P. aeruginosa reflect
results found on BAL fluid analysis, suggesting these are reasonable surrogates to determine lung colonization with P. aeruginosa. However, sputum and throat culture findings of
S. aureus do not appear to reflect S. aureus colonization of the lung.
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Introduction
Patients with cystic fibrosis (CF) are plagued by chronic respiratory infections and inflammation leading to progressive bronchiectasis and, ultimately, respiratory failure. Pulmonary disease is the leading cause of morbidity and mortality in CF [1]. The prevalence of each
microbial species varies with age. The most prevalent species are Pseudomonas aeruginosa and
Staphylococcus aureus. P. aeruginosa is recognized as the main pathogen responsible for the
morbidity and mortality of CF patients [2–4]. The prevalence of P. aeruginosa infection
increases with age and more than 80% of patients older than 19 years are chronically infected
[2, 4–6]. Chronic infections with S. aureus, both methicillin sensitive (MSSA) and methicillin
resistant (MRSA) are also on the rise for the CF population as a whole [4]. Early identification
of S. aureus is important, as MRSA is associated with an adverse outcome [7, 8]. Therefore, an
accurate assessment of lower respiratory tract colonization is critical to inform accurate
therapy.
Quarterly respiratory cultures are obtained as standard of care to inform treatment, a practice based on non-evidence based guidelines [4, 9]. Though sputum is preferred over throat culture [10], not all patients are able to spontaneously produce a sputum sample. In fact only 35–
40% of pediatric patients produce sufficient sputum to be sent for culture [11, 12]. When
patients are unable to produce a sputum sample, clinicians often obtain throat swabs and send
them for culture as a surrogate for lower respiratory tract cultures. This practice may be useful
in subjects not known to be colonized with P. aeruginosa in order to catch asymptomatic
patients with first time colonization, but its clinical utility in the adult CF population is unclear
[9, 13]. In fact Armstrong et al. argue that oropharyngeal cultures are poor predictors of pathogens in children with CF [14]. As it stands we don’t know how accurate sputum cultures and
throat swabs are compared to the gold standard of bronchoalveolar lavage (BAL). Our aim in
this study is to determine the reliability of throat cultures and sputum cultures.
Despite arguments against throat swabs as standard of care in children who cannot produce
sputum, others found that throat swabs show excellent concordance with cultures obtained
from a bronchoalveolar lavage [11]. In addition, in children <18 months Rosenfeld et al found
that compared to BAL, oropharyngeal cultures for P. aeruginosa yield a sensitivity of 44%,
specificity of 95%, positive predictive value (PPV) of 44% and negative predictive value (NPV)
of 95% [15]. Ramsey et al report a PPV of 83% for P. aeruginosa and a PPV of 91% for S. aureus
in non-expectorating subjects <10 years of age [11]. To complicate matters, throat swabs may
underestimate bacteria associated with airway inflammation in subjects age 8–21 years [13].
While there are ample data describing the relationship between throat swab and BAL cultures
in children, there are minimal data looking at the predictive value of throat swabs and sputum
in adult patients with CF. In this study, we sought to determine the positive and negative predictive value of throat and sputum culture for the most common CF organisms.

Materials and Methods
Human Subjects
This study was approved by the Committee for the Protection of Human Subjects at the Geisel
School of Medicine at Dartmouth. Following written informed consent, subjects underwent a
throat swab, which was sent for standard CF culture. Throat swab samples were obtained by
the same provider in all subjects by swabbing the posterior oropharynx. If the subject was able
to spontaneously expectorate, a sputum sample was also sent for culture. Subsequently, flexible
bronchoscopy was performed. Briefly, a bronchoscope was passed through the vocal cords
after local anesthesia with viscous lidocaine to the posterior pharynx and intravenous sedation.
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No suction was used prior to obtaining the BAL sample to ensure that the suction channel was
not contaminated. BAL fluid was obtained from the anterior segment of the right upper lobe
(RUL) and sent for culture. In all subjects, 20cc of sterile saline was inserted into the RUL and
aspirated back into a sterile container. Following the procedure, subjects were monitored until
they were stable for discharge. In a subset of subjects (n = 3), two bronchoscopes were used and
the first bronchoscope was inserted to just above the vocal cord and the channel was washed
with normal saline and cultured to assess for oral contamination during the bronchoscopy procedure. Adult CF Subjects (n = 20) were enrolled if they were not currently having an exacerbation and were non-smokers. While subjects could be on a chronic inhaled antibiotic regimen,
all subjects had been off antibiotics for exacerbation treatment for at least 28 days. All female
subjects underwent a pregnancy test and were excluded if positive.

Microbiology Culture
Specimens of expectorated sputum, BAL, and deep throat swabs were processed following the
recommendations of the Microbiology Working Group of the Northern New England Cystic
Fibrosis Consortium and the Microbiology Consensus Conference of the Cystic Fibrosis Foundation [4]. Gram stains were performed on all specimens and no specimen was rejected
because of upper respiratory contamination. The most purulent portion of a specimen was
identified, inoculated onto agar plates by swab and streaked for isolation of colonies. Media
inoculated were 5% sheep blood agar, chocolate agar, colistin/nalidixic acid agar, MacConkey
agar, mannitol-salt agar, and oxidation-fermentation polymyxin bacitracin lactose agar (all
from Remel, Lenexa Kansas). Agar plates were incubated at 35 degrees centigrade for a minimum of 72 hours, and observed for growth of pathogens specified by the CF Consensus document, including Staphylococcus aureus, beta-hemolytic streptococci, Streptococcus pneumoniae,
Streptococcus milleri group, Haemophilus influenza, Moraxella catarrhalis, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter secies, Acinetobacter species, Burkholderia species and yeast.

Statistical Analyses
Sample size calculation was determined using G Power Statistical Software. Using a Fisher’s
Exact Test and setting the phi coefficient at 0.7 (strong positive association), we would need to
enroll 20 subjects to detect a positive association with a power of 90%. Statistical analyses of
data were performed using GraphPad Prism 6 for Mac OS X software version 6.0h (Prism, San
Diego, CA) and the R software environment for statistical computing and graphics [16].

Results
Patient Characteristics
A total of 20 subjects with CF were enrolled in this study. The demographic and genetic attributes of this cohort are listed in Table 1. The median age of the cohort was 27 years. All subjects possessed at least one F508del-CFTR allele.

Microbiological Relationship between BAL Fluid Culture, Sputum
Culture, and Throat Culture
BAL fluid culture and throat culture were obtained from 20 subjects with CF. Cultures were
processed via standard methodology at the DHMC Microbiology Laboratory and within the
guidelines of the Cystic Fibrosis Foundation [4]. In all cases, the throat swab was obtained
immediately prior to the bronchoscopy. A subset of subjects (n = 12) also had a spontaneously
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Table 1. Patient Characteristics.
Subject

Age (y)

Gender

FEV1 (% predicted)

Sputum PA

Sputum Staph

Throat PA

Throat Staph

BAL PA

1

25

M

64%

Y

Y

Y

Y

Y

BAL Staph
N

2

28

M

117%

Y

N

Y

Y

Y

N

3

28

M

88%

ND

ND

N

Y

N

Y

4

31

M

90%

ND

ND

N

Y

Y

N

5

24

M

60%

N

Y

N

Y

Y

Y

6

24

M

84%

N

Y

N

Y

N

N

7

25

F

85%

Y

N

Y

Y

Y

N

8

27

M

72%

Y

N

Y

N

Y

N

9

34

F

56%

Y

N

Y

N

Y

N

10

21

M

92%

N

Y

N

Y

N

Y

11

36

M

106%

ND

ND

N

Y

Y

Y

12

28

F

82%

ND

ND

Y

Y

Y

N

13

22

F

65%

Y

Y

N

Y

Y

Y

14

21

F

86%

N

Y

N

Y

Y

N

15

30

M

73%

N

Y

N

Y

N

Y

16

19

M

116%

ND

ND

N

Y

N

N

17

53

M

74%

ND

ND

N

Y

N

N

18

20

F

63%

ND

ND

N

Y

N

N

19

37

M

94%

ND

ND

N

Y

Y

Y

20

26

M

51%

Y

N

N

N

Y

N

PA: Pseudomonas aeruginosa; Staph: Staphylococcus aureus; ND: not done
doi:10.1371/journal.pone.0164232.t001

expectorated sputum sample obtained for culture on the same day and prior to the
bronchoscopy.
To assess for contamination of BAL fluid by oral flora, in a subset of subjects (n = 3) a scope
was with normal saline was performed before the bronchoscope was inserted past the vocal
cord. In 2 subjects, standard culture revealed only “normal oral flora” in the scope wash and
did not demonstrate a predominant organism. In the third subject, no bacteria were isolated
from the scope wash. These data suggest that the culture results obtained in BAL fluid do not
reflect contamination of the bronchoscope by oral flora.
We calculated specificity, sensitivity, positive predictive value (PPV) and negative predictive
value (NPV) of throat culture results for the two most common CF pathogens as identified by
Cystic Fibrosis Foundation registry data using BAL culture results as the gold standard. Comparing sputum to BAL for P. aeruginosa, we found a sensitivity of 78%, specificity of 100%,
PPV of 100%, and NPV of 60%. For S. aureus found in sputum versus BAL we calculated a sensitivity of 100%, specificity of 63%, PPV of 57%, and NPV of 100%. Analyzing throat swab P.
aeruginosa compared to BAL, we found a 46% sensitivity, and 100% specificity yielding a PPV
of 100% and NPV of 50%. Throat swab compared to BAL for S. aureus showed a sensitivity of
100%, specificity of 23%, PPV of 41%, and NPV of 100%.
We calculated the phi coefficient to measure the degree of association between BAL and
throat culture, BAL and sputum culture or throat and sputum culture for both P. aeruginosa
and S. aureus (Fig 1). A phi coefficient above 0.7 signifies a strong positive association, between
0.7 and 0.3 indicates a weak positive association and below 0.3 suggests little or no association.
The correlations between P. aeruginosa BAL and sputum culture and throat and sputum culture as well as S. aureus throat and sputum culture were statistically significant as determined
by Fisher’s Exact Test (p < 0.05). Meanwhile, the correlations between S. aureus BAL and
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Fig 1. Comparison of Methods for Determining Bacterial Colonization. Clinical samples were obtained from CF subjects (n = 20 for BAL and throat
swab and n = 12 for sputum). The phi coefficient was used to measure the degree of association between positive and negative cultures for P. aeruginosa
and S. aureus in BAL fluid, sputum and throat swabs. Throat swabs and sputum were significantly correlated for both pathogens, as were BAL fluid and
sputum for P. aeruginosa (p < 0.05 as determined with Fisher’s Exact Test and indicated by an asterisk).
doi:10.1371/journal.pone.0164232.g001

sputum culture and BAL and throat cultures for both pathogens failed to reach statistical
significance.

Discussion
Our data demonstrate that positive sputum and throat culture findings of P. aeruginosa reflect
results found in BAL fluid analysis, suggesting these are reasonable surrogates to determine
lung colonization with P. aeruginosa. The diagnostic challenge lies within those subjects that
have a negative throat swab or sputum culture as we cannot rely on this to rule out lung colonization as our data found a low negative predictive value for P. aeruginosa in both sputum and
throat cultures. In adult subjects with CF, sputum and throat culture findings of S. aureus do
not appear to reflect S. aureus colonization of the lung. However, a negative throat swab for S.
aureus suggests that the organism is likely not present at all. This is very intuitive as S. aureus is
known to colonize the upper airways but this does not necessarily reflect lung colonization.
Obtaining a “standard” culture may lead to identification of a particular organism, but may
be subject to differences in competitive growth patterns in vitro versus in vivo. A weakness of
our study is the use of conventional culture without using deep sequencing techniques. 16S
ribosomal RNA (rRNA) gene sequencing allows for detection of a larger number of potential
pathogens. Only a small fraction of all bacteria can be successfully cultured, while clinically significant organisms may be slow-growing, fastidious, inert, or unviable [17, 18]. Standard culture typically only shows the most abundant organism(s), whereas DNA based techniques can
detect minor species, which may be just as important in influencing the pathogenicity and
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potential inflammatory changes [19, 20]. Consistent with prior studies [21], we recently
reported that the sputum microbiome is different from the BAL microbiome in a cohort of
adult patients with CF [22]. However, standard clinical practice is to perform quarterly cultures
for identification of dominant pathogen(s) so our study sought to investigate how reliable
throat and sputum cultures are using the standard methodology. Our future investigations will
focus on differences in the microbiome using these more advanced techniques.
Our study was powered to investigate differences in identification of the two most common
CF pathogens (S. aureus and P. aeruginosa). We recognize that there are many other important
pathogens in CF and a potential weakness of our current study was the lack of investigation of
these other important bacterial species. However, given that most eradication protocols used
clinically are directed at these two most common pathogens [23, 24], early and accurate identification of colonization with S. aureus and P. aeruginosa is critical for the effective management
of our patients. In addition, despite adequate power, our study is limited by its small sample
size and single site. Our future studies will enroll subjects at multiple sites to increase our sample size and allow investigation of geographic differences. Although the microbiome literature
suggests stability of the microbiome over time in an individual patient, it is well described that
CF patients can be transiently colonized with specific bacteria. A limitation of our study is that
it involves a single visit rather than evaluating serial samples.
An important aspect of our study is that it helps the clinician to identify the optimal sampling technique in a clinical context. The predictive value of throat cultures was thoroughly
analyzed by Ramsey et al and they found that in non-expectorating patients less than 10 years
of age a positive result for P. aeruginosa was 83% predictive (95% confidence interval 36 to
100%), while S. aureus was 91% predictive (59 to 100%). Negative throat cultures yielded 70%
(48 to 86%) for P. aeruginosa and 80% (52 to 96%) for S. aureus [11]. More recently, sputum in
children (both induced and spontaneously expectorated) has been compared to throat swab
using quantitative PCR concluding that throat swabs may underestimate bacteria associated
with airway inflammation [13]. This is consistent with our recent study demonstrating that the
microbiome of sputum from CF patients is different from that found in BAL and protected
brush samples [22]. Our current data clearly demonstrate that the absence of P. aeruginosa on
throat culture is not adequate to determine if P. aeruginosa is present in the lung of stable adult
CF patients. Further studies using deep sequencing are needed to identify the accuracy of
throat and sputum culture in representing the lung microbiome. In addition, studies involving
a larger and more diverse patient population will allow for more generalizable findings. If significant differences between BAL and throat swab cultures are found, then the practice of quarterly surveillance cultures using throat swabs as a surrogate for samples obtained from the lung
may be challenged.
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